The Global Chromatography Media for Biopharmaceutical Market was valued at USD 3.2 Billion in 2023 and is projected to reach USD 5.8 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period (2024–2030). This growth is driven by increasing biopharmaceutical R&D, rising demand for monoclonal antibodies, and stringent regulatory requirements for drug purity testing.
As the biopharmaceutical industry expands globally, the need for advanced purification solutions has never been greater. Chromatography media plays a critical role in bioprocessing, enabling the separation and purification of complex biological molecules. In this report, we profile the Top 10 Companies in the Chromatography Media for Biopharmaceutical Market—industry leaders who are shaping the future of bioprocessing through innovation and technological advancement.
🔟 1. GE Healthcare (Cytiva)
Headquarters: Marlborough, Massachusetts, USA
Key Offering: Capto chromatography resins, ÄKTA systems
GE Healthcare, now operating as Cytiva, is the global leader in chromatography media for biopharmaceuticals. Their portfolio includes agarose-based resins for all major chromatography modes, supporting large-scale monoclonal antibody production.
Recent Developments:
- Launched Capto Resin High-Sub platform for high-capacity binding
- Expanded continuous bioprocessing solutions
- Invested in new manufacturing facilities in China and Sweden
Download FREE Sample Report:
